Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism TGF-β1 inhibitors(Transforming growth factor beta 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bone metastases | Discovery | ES | - | |
Dystrophy, Macular | Discovery | ES | - | |
Hepatocellular Carcinoma | Discovery | ES | - | |
Liver Cirrhosis | Discovery | ES | - | |
Melanoma | Discovery | ES | - | |
Pulmonary Fibrosis | Discovery | ES | - |